Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nishant Mohan

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Oncotarget|February 22, 2018
Type IIB DNA topoisomerase is downregulated by trastuzumab and doxorubicin to synergize cardiotoxicityJiangsong Jiang, Nishant Mohan, Yukinori Endo, et al.
Scientific Reports|November 10, 2019
Cell proliferation and invasion are regulated differently by EGFR and MRP1 in T-DM1-resistant breast cancer cellsYukinori Endo, Sarah Lyon, Yi Shen, et al.
Molecular Oncology|January 16, 2013
KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cellsNishant Mohan, Walden Ai, Mrinmay Chakrabarti, et al.
Molecular Cancer Therapeutics|May 20, 2016
Trastuzumab, but Not Pertuzumab, Dysregulates HER2 Signaling to Mediate Inhibition of Autophagy and Increase in Reactive Oxygen Species Production in Human CardiomyocytesNishant Mohan, Yi Shen, Yukinori Endo, et al.
Mabs|August 22, 2018
T-DM1-resistant cells gain high invasive activity via EGFR and integrin cooperated pathwaysYukinori Endo, Yi Shen, Lamis Abou Youssef, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 3, 2017
Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumabMilos Dokmanovic, Kathryn E King, Nishant Mohan, et al.
Brain Research|June 10, 2009
Bcl-2 inhibitor HA14-1 and genistein together adeptly down regulated survival factors and activated cysteine proteases for apoptosis in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cellsNishant Mohan, Surajit Karmakar, Subhasree Roy Choudhury, et al.
Retinal Cases & Brief Reports|July 23, 2025
Home Optical Coherence Tomography-guided Management of Type 3 Macular NeovascularizationLivia Faes, Nancy Holekamp, Gidi Benyamini, et al.
Oncotarget|July 14, 2016
VPS34 regulates TSC1/TSC2 heterodimer to mediate RheB and mTORC1/S6K1 activation and cellular transformationNishant Mohan, Yi Shen, Milos Dokmanovic, et al.
Oncotarget|January 17, 2019
Payload of T-DM1 binds to cell surface cytoskeleton-associated protein 5 to mediate cytotoxicity of hepatocytesYukinori Endo, Kazuyo Takeda, Nishant Mohan, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Oncotarget|February 22, 2018
Type IIB DNA topoisomerase is downregulated by trastuzumab and doxorubicin to synergize cardiotoxicityJiangsong Jiang, Nishant Mohan, Yukinori Endo, et al.
Scientific Reports|November 10, 2019
Cell proliferation and invasion are regulated differently by EGFR and MRP1 in T-DM1-resistant breast cancer cellsYukinori Endo, Sarah Lyon, Yi Shen, et al.
Molecular Oncology|January 16, 2013
KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cellsNishant Mohan, Walden Ai, Mrinmay Chakrabarti, et al.
Molecular Cancer Therapeutics|May 20, 2016
Trastuzumab, but Not Pertuzumab, Dysregulates HER2 Signaling to Mediate Inhibition of Autophagy and Increase in Reactive Oxygen Species Production in Human CardiomyocytesNishant Mohan, Yi Shen, Yukinori Endo, et al.
Mabs|August 22, 2018
T-DM1-resistant cells gain high invasive activity via EGFR and integrin cooperated pathwaysYukinori Endo, Yi Shen, Lamis Abou Youssef, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 3, 2017
Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumabMilos Dokmanovic, Kathryn E King, Nishant Mohan, et al.
Brain Research|June 10, 2009
Bcl-2 inhibitor HA14-1 and genistein together adeptly down regulated survival factors and activated cysteine proteases for apoptosis in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cellsNishant Mohan, Surajit Karmakar, Subhasree Roy Choudhury, et al.
Retinal Cases & Brief Reports|July 23, 2025
Home Optical Coherence Tomography-guided Management of Type 3 Macular NeovascularizationLivia Faes, Nancy Holekamp, Gidi Benyamini, et al.
Oncotarget|July 14, 2016
VPS34 regulates TSC1/TSC2 heterodimer to mediate RheB and mTORC1/S6K1 activation and cellular transformationNishant Mohan, Yi Shen, Milos Dokmanovic, et al.
Oncotarget|January 17, 2019
Payload of T-DM1 binds to cell surface cytoskeleton-associated protein 5 to mediate cytotoxicity of hepatocytesYukinori Endo, Kazuyo Takeda, Nishant Mohan, et al.
Pageof 4